PharmGKB Blog
Friday, June 26, 2015

Medication Safety Code Initiative Looking for Survey Participants

›
The Medication Safety Code (MSC) Initiative ( http://safety-code.org/ ) aims to improve the portability of pharmacogenetic data by enabling...
Friday, June 12, 2015

CPIC Guideline Update for Allopurinol and HLA-B*58:01 Published

›
The 2015 update of CPIC guideline for allopurinol and HLA-B*58:01 has been published in Clinical Pharmacology and Therapeutics. CPIC exte...
Thursday, June 11, 2015

March/April SNPits Summary

›
In the March/April issue of UF Health Personalized Medicine Program's e-newsletter, SNPits , a recent study in the Lancet supports the ...
Wednesday, June 10, 2015

Annotated Health Canada product monographs now available on PharmGKB

›
PharmGKB now has annotated drug labels (referred to as product monographs) available from Health Canada/Santé Canada (HCSC). PDF copies of...
Monday, June 8, 2015

NIGMS announces funding changes for PGRN

›
NIGMS announces the transition of pharmacogenomics research from set-aside funding to regular competition.  The FOA for Research Centers fo...
Monday, May 18, 2015

PharmGKB efavirenz pharmacokinetic pathway published in Pharmacogenetics and Genomics

›
The PharmGKB summary describing the efavirenz (EFV) pharmacokinetic pathway, and the pharmacogenetic variants that affect EFV pharmacokinet...
Monday, May 11, 2015

New CPIC Guideline: CYP2D6 and CYP2C19 and Selective Serotonin Reuptake Inhibitors

›
Guidelines by the Clinical Pharmacogenetics Implementation Consortium ( CPIC ) regarding the use of pharmacogenetic tests for CYP2D6 and CY...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.